Von Eschenbach "to be nominated" next FDA chief

13 March 2006

An unconfirmed report is circulating that acting-commissioner at the US Food and Drug Administration Andrew Von Eschenbach is to be nominated by US President George W Bush to assume the position on a permanent basis. The appointment would need to be confirmed by the US Senate.

The story appeared on Peter Pitts' Drugwonks.com blog. Mr Pitts is a former FDA Associate Commissioner for External Relations and currently Senior Fellow for health care studies at the San Francisco, USA-based think tank, the Pacific Research Institute.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight